Literature DB >> 375666

Cochlear hearing loss and viral infection.

G Djupesland, G Flottorp, M Degré, R Stien, S Skrede.   

Abstract

A group of about 100 consecutive patients admitted to an otorhinolaryngological outpatient department for treatment of cranial nerve affections underwent detailed neurological, audiological and laboratory examinations. Of 34 patients with hearing loss, objective signs of viral infection were found in 12. The hearing loss was sensorineural of the cochlear type, in 7 cases of the high-frequency type, in 5 cases of the low-frequency (Menière) type. Within one year after the onset of the disease the hearing loss had disappeared in all but 2 cases. Reversible dysfunction of two or more cranial nerves was found in 7 of 8 cases examined. In the cerebrospinal fluid the cell count and the total protein and gamma-globulin values were increased in most patients. Our findings indicate a reversible sensorineural hearing loss to be part of a viral-induced meningoencephalitis and cranial polyneuropathy. The mechanism of the reversible low- and high-frequency hearing loss is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 375666     DOI: 10.3109/00016487909126416

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  The pathology of idiopathic sudden sensorineural hearing loss.

Authors:  H F Schuknecht; E D Donovan
Journal:  Arch Otorhinolaryngol       Date:  1986

2.  Tinnitus and 3-Year Change in Audiometric Hearing Thresholds.

Authors:  Sharon G Curhan; Christopher Halpin; Molin Wang; Roland D Eavey; Gary C Curhan
Journal:  Ear Hear       Date:  2021 July/Aug       Impact factor: 3.562

3.  Hearing thresholds in patients with drug-resistant tuberculosis: baseline audiogram configurations and associations.

Authors:  Olusola Ayodele Sogebi; Muse Olatunbosun Fadeyi; Bolanle Olufunlola Adefuye; Festus Olukayode Soyinka
Journal:  J Bras Pneumol       Date:  2017 May-Jun       Impact factor: 2.624

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.